Rank | Gene Set | Z-score |
---|---|---|
1 | purine nucleotide salvage (GO:0032261) | 7.11781998 |
2 | folic acid-containing compound biosynthetic process (GO:0009396) | 6.48388868 |
3 | regulation of plasminogen activation (GO:0010755) | 6.45451955 |
4 | homocysteine metabolic process (GO:0050667) | 6.08291092 |
5 | sulfur amino acid catabolic process (GO:0000098) | 5.92580526 |
6 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.45868182 |
7 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.90523820 |
8 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.90523820 |
9 | cysteine metabolic process (GO:0006534) | 4.72485942 |
10 | white fat cell differentiation (GO:0050872) | 4.64854369 |
11 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 4.52031159 |
12 | regulation of vitamin metabolic process (GO:0030656) | 4.49586099 |
13 | adenosine metabolic process (GO:0046085) | 4.44583543 |
14 | nucleotide salvage (GO:0043173) | 4.38796243 |
15 | pteridine-containing compound biosynthetic process (GO:0042559) | 4.27177456 |
16 | DNA deamination (GO:0045006) | 4.24886299 |
17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.21371005 |
18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.21371005 |
19 | phosphatidylglycerol biosynthetic process (GO:0006655) | 4.17292142 |
20 | desmosome organization (GO:0002934) | 4.12807866 |
21 | negative regulation of DNA biosynthetic process (GO:2000279) | 4.10479448 |
22 | microtubule nucleation (GO:0007020) | 4.09447306 |
23 | cell migration involved in heart development (GO:0060973) | 4.05360844 |
24 | signal peptide processing (GO:0006465) | 4.04413325 |
25 | regulation of cholesterol storage (GO:0010885) | 3.99327294 |
26 | tolerance induction (GO:0002507) | 3.99078294 |
27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.88999589 |
28 | alternative mRNA splicing, via spliceosome (GO:0000380) | 3.88471040 |
29 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.68614551 |
30 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.62135688 |
31 | galactose catabolic process (GO:0019388) | 3.57768454 |
32 | proteasome assembly (GO:0043248) | 3.56279244 |
33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.51960706 |
34 | glycosphingolipid catabolic process (GO:0046479) | 3.51371339 |
35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.46155012 |
36 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.45729913 |
37 | regulation of superoxide anion generation (GO:0032928) | 3.42004240 |
38 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.40281755 |
39 | negative regulation of catenin import into nucleus (GO:0035414) | 3.39773582 |
40 | negative regulation of cell size (GO:0045792) | 3.36237368 |
41 | sequestering of actin monomers (GO:0042989) | 3.34737090 |
42 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.30723048 |
43 | regulation of sequestering of triglyceride (GO:0010889) | 3.27241663 |
44 | regulation of tight junction assembly (GO:2000810) | 3.25164856 |
45 | IMP biosynthetic process (GO:0006188) | 3.21534209 |
46 | platelet dense granule organization (GO:0060155) | 3.21179773 |
47 | negative regulation of Ras GTPase activity (GO:0034261) | 3.19771466 |
48 | oxygen transport (GO:0015671) | 3.16999562 |
49 | regulation of gonadotropin secretion (GO:0032276) | 3.15579745 |
50 | purine-containing compound salvage (GO:0043101) | 3.14931246 |
51 | galactose metabolic process (GO:0006012) | 3.13762951 |
52 | glycolipid catabolic process (GO:0019377) | 3.13438727 |
53 | response to thyroid hormone (GO:0097066) | 3.11481170 |
54 | polyamine biosynthetic process (GO:0006596) | 3.07595157 |
55 | metallo-sulfur cluster assembly (GO:0031163) | 3.07356623 |
56 | iron-sulfur cluster assembly (GO:0016226) | 3.07356623 |
57 | cellular response to zinc ion (GO:0071294) | 3.06538070 |
58 | regulation of RIG-I signaling pathway (GO:0039535) | 3.05994566 |
59 | positive regulation of histone acetylation (GO:0035066) | 3.03400016 |
60 | endosome to melanosome transport (GO:0035646) | 3.02587573 |
61 | endosome to pigment granule transport (GO:0043485) | 3.02587573 |
62 | response to vitamin A (GO:0033189) | 3.02546717 |
63 | negative regulation of necroptotic process (GO:0060546) | 3.00073252 |
64 | NIK/NF-kappaB signaling (GO:0038061) | 2.97850909 |
65 | response to peptidoglycan (GO:0032494) | 2.97605608 |
66 | folic acid-containing compound metabolic process (GO:0006760) | 2.96775935 |
67 | mitochondrial RNA metabolic process (GO:0000959) | 2.96125727 |
68 | GDP-mannose metabolic process (GO:0019673) | 2.93051871 |
69 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.92983066 |
70 | negative regulation of lipid storage (GO:0010888) | 2.91563329 |
71 | cellular response to type I interferon (GO:0071357) | 2.89952968 |
72 | type I interferon signaling pathway (GO:0060337) | 2.89952968 |
73 | cytochrome complex assembly (GO:0017004) | 2.89948952 |
74 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.88281554 |
75 | energy homeostasis (GO:0097009) | 2.87743301 |
76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.87549747 |
77 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.87516026 |
78 | mast cell activation (GO:0045576) | 2.87496368 |
79 | negative regulation of cell killing (GO:0031342) | 2.87299060 |
80 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.87299060 |
81 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.87066581 |
82 | respiratory chain complex IV assembly (GO:0008535) | 2.86629770 |
83 | folic acid metabolic process (GO:0046655) | 2.86535202 |
84 | response to type I interferon (GO:0034340) | 2.86377538 |
85 | ribosomal small subunit assembly (GO:0000028) | 2.85239526 |
86 | regulation of relaxation of muscle (GO:1901077) | 2.84589655 |
87 | nucleoside diphosphate catabolic process (GO:0009134) | 2.82594120 |
88 | interferon-gamma production (GO:0032609) | 2.81812323 |
89 | IMP metabolic process (GO:0046040) | 2.79984212 |
90 | positive regulation of B cell differentiation (GO:0045579) | 2.77960385 |
91 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.76112868 |
92 | histone H4-K12 acetylation (GO:0043983) | 2.75059497 |
93 | regulation of DNA biosynthetic process (GO:2000278) | 2.74775854 |
94 | COPI coating of Golgi vesicle (GO:0048205) | 2.73102852 |
95 | Golgi transport vesicle coating (GO:0048200) | 2.73102852 |
96 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.72729801 |
97 | ceramide catabolic process (GO:0046514) | 2.71832128 |
98 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.71356294 |
99 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.70595161 |
100 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.70595161 |
101 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.69673317 |
102 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.69321042 |
103 | nucleoside transmembrane transport (GO:1901642) | 2.67501854 |
104 | folic acid transport (GO:0015884) | 2.66873113 |
105 | protein complex biogenesis (GO:0070271) | 2.65652540 |
106 | negative regulation of telomerase activity (GO:0051974) | 2.62200495 |
107 | oxidative phosphorylation (GO:0006119) | 2.61660550 |
108 | negative regulation of alcohol biosynthetic process (GO:1902931) | 2.60722970 |
109 | negative regulation of anoikis (GO:2000811) | 2.60718021 |
110 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.60182518 |
111 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.58903313 |
112 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.58443622 |
113 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.57915224 |
114 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.57685797 |
115 | positive regulation of extracellular matrix organization (GO:1903055) | 2.57312042 |
116 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.57245646 |
117 | glycoside metabolic process (GO:0016137) | 2.56090571 |
118 | neutrophil activation involved in immune response (GO:0002283) | 2.56074306 |
119 | tetrahydrofolate metabolic process (GO:0046653) | 2.56004059 |
120 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.55051059 |
121 | positive regulation of peptidyl-lysine acetylation (GO:2000758) | 2.54897154 |
122 | positive regulation of protein acetylation (GO:1901985) | 2.54897154 |
123 | regulation of anoikis (GO:2000209) | 2.53849425 |
124 | regulation of gamma-delta T cell activation (GO:0046643) | 2.53274573 |
125 | adhesion of symbiont to host cell (GO:0044650) | 2.53165901 |
126 | virion attachment to host cell (GO:0019062) | 2.53165901 |
127 | peptidyl-proline hydroxylation (GO:0019511) | 2.52143344 |
128 | regulation of necrotic cell death (GO:0010939) | 2.51316312 |
129 | negative regulation of interleukin-1 production (GO:0032692) | 2.50320994 |
130 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.49672849 |
131 | termination of RNA polymerase III transcription (GO:0006386) | 2.49672849 |
132 | inner ear receptor cell development (GO:0060119) | 2.49270406 |
133 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.49133860 |
134 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.49133860 |
135 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.48806619 |
136 | positive regulation of protein dephosphorylation (GO:0035307) | 2.48733858 |
137 | rRNA methylation (GO:0031167) | 2.47281701 |
138 | response to parathyroid hormone (GO:0071107) | 2.47236172 |
139 | negative regulation of phagocytosis (GO:0050765) | 2.45591853 |
140 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.45221779 |
141 | myeloid dendritic cell activation (GO:0001773) | 2.44899832 |
142 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.44221710 |
143 | regulation of endothelial cell differentiation (GO:0045601) | 2.43991666 |
144 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.43778256 |
145 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.43417446 |
146 | T cell migration (GO:0072678) | 2.43219759 |
147 | negative regulation of necrotic cell death (GO:0060547) | 2.41790500 |
148 | regulation of superoxide metabolic process (GO:0090322) | 2.41656709 |
149 | mature B cell differentiation involved in immune response (GO:0002313) | 2.41336493 |
150 | heart contraction (GO:0060047) | 2.40087892 |
151 | heart process (GO:0003015) | 2.40087892 |
152 | positive regulation of mitochondrial fission (GO:0090141) | 2.39425316 |
153 | protein maturation by protein folding (GO:0022417) | 2.38856276 |
154 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.38590706 |
155 | leukocyte aggregation (GO:0070486) | 2.37064593 |
156 | negative regulation of innate immune response (GO:0045824) | 2.34838001 |
157 | barbed-end actin filament capping (GO:0051016) | 2.34260988 |
158 | response to interferon-beta (GO:0035456) | 2.32238674 |
159 | positive regulation of antigen processing and presentation (GO:0002579) | 2.31830714 |
160 | peptidyl-histidine modification (GO:0018202) | 2.31793670 |
161 | cellular response to interferon-beta (GO:0035458) | 2.31742015 |
162 | fibril organization (GO:0097435) | 2.30490037 |
163 | defense response to protozoan (GO:0042832) | 2.30005578 |
164 | mast cell degranulation (GO:0043303) | 2.29884365 |
165 | mast cell activation involved in immune response (GO:0002279) | 2.29884365 |
166 | rRNA modification (GO:0000154) | 2.29390755 |
167 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.29379894 |
168 | myeloid dendritic cell differentiation (GO:0043011) | 2.27821305 |
169 | deoxyribonucleotide catabolic process (GO:0009264) | 2.27197349 |
170 | regulation of mitochondrial translation (GO:0070129) | 2.25596301 |
171 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.25534090 |
172 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.23394859 |
173 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 2.21883389 |
174 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.20051328 |
175 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.19993673 |
176 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.18459476 |
177 | protein retention in ER lumen (GO:0006621) | 2.17999146 |
178 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.17001251 |
179 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.16183806 |
180 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.15877961 |
181 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.15865028 |
182 | response to protozoan (GO:0001562) | 2.15504290 |
183 | deoxyribose phosphate catabolic process (GO:0046386) | 2.14938742 |
184 | respiratory burst (GO:0045730) | 2.14769560 |
185 | regulation of response to interferon-gamma (GO:0060330) | 2.14551252 |
186 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.14201713 |
187 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.13591457 |
188 | regulation of necroptotic process (GO:0060544) | 2.12984973 |
189 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.12737231 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.52532537 |
2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.92010758 |
3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.12478655 |
4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.12158103 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.96670631 |
6 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.88667103 |
7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.88295277 |
8 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.75513775 |
9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.75112573 |
10 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.72538472 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.67041918 |
12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.58173420 |
13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57898215 |
14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.56932980 |
15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.53446183 |
16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.53259116 |
17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.50833451 |
18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.49855012 |
19 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.47652546 |
20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.40654418 |
21 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34121883 |
22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.24281947 |
23 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.09493302 |
24 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.04921334 |
25 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.04367114 |
26 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02942462 |
27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.98694422 |
28 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97082665 |
29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.96424989 |
30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.94297872 |
31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.91475370 |
32 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.89328849 |
33 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.87077729 |
34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.84536951 |
35 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.82756838 |
36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.81274486 |
37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.79470310 |
38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.78995876 |
39 | MYB_26560356_Chip-Seq_TH2_Human | 1.78832118 |
40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.77763899 |
41 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.77555144 |
42 | P68_20966046_ChIP-Seq_HELA_Human | 1.75707587 |
43 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.75592364 |
44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72778846 |
45 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.71962063 |
46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71536152 |
47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.68316335 |
48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68250385 |
49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.67006927 |
50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.66162385 |
51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65203026 |
52 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.65033977 |
53 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.63087466 |
54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.60856538 |
55 | MYC_22102868_ChIP-Seq_BL_Human | 1.59742855 |
56 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.59242771 |
57 | MAF_26560356_Chip-Seq_TH1_Human | 1.58061009 |
58 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.56700496 |
59 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.56668406 |
60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56467688 |
61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.54890878 |
62 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.54520795 |
63 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.52901058 |
64 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.51935397 |
65 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51786961 |
66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.51057319 |
67 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.50987775 |
68 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50376868 |
69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.49957504 |
70 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.48570788 |
71 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48136784 |
72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45526789 |
73 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45361608 |
74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.45196921 |
75 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.44556064 |
76 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.41656967 |
77 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.40393501 |
78 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.38792318 |
79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38412410 |
80 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.38050370 |
81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37651134 |
82 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.35592204 |
83 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35148635 |
84 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.34895769 |
85 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.34103696 |
86 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33277342 |
87 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.32245798 |
88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31907384 |
89 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31202782 |
90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.31154473 |
91 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31125656 |
92 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30325018 |
93 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28394189 |
94 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.28356604 |
95 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25576176 |
96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25505078 |
97 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.25169426 |
98 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24968016 |
99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24932305 |
100 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.24761176 |
101 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24631259 |
102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24518287 |
103 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.24160982 |
104 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.23973185 |
105 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23917951 |
106 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23036031 |
107 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22695371 |
108 | MAF_26560356_Chip-Seq_TH2_Human | 1.22477927 |
109 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.21771677 |
110 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21141155 |
111 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.21077693 |
112 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.20032243 |
113 | MYB_26560356_Chip-Seq_TH1_Human | 1.19948068 |
114 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.19028268 |
115 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18906482 |
116 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.18408866 |
117 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.18291764 |
118 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.18101865 |
119 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.16983274 |
120 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15381267 |
121 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.15063576 |
122 | ATF3_27146783_Chip-Seq_COLON_Human | 1.14943315 |
123 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14352214 |
124 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14197879 |
125 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13887254 |
126 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13845702 |
127 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13204934 |
128 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13064271 |
129 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13045197 |
130 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12733295 |
131 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11326299 |
132 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10956788 |
133 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.10214665 |
134 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.09765102 |
135 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.09643720 |
136 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09399322 |
137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08495441 |
138 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08382605 |
139 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08225677 |
140 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07495408 |
141 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07352822 |
142 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07192862 |
143 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07148194 |
144 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07083732 |
145 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06999497 |
146 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04618211 |
147 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.04128373 |
148 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04063654 |
149 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.03981219 |
150 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02990566 |
151 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.02316561 |
152 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01553728 |
153 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99901143 |
154 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99447378 |
155 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.99377511 |
156 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99363086 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003705_abnormal_hypodermis_morpholog | 4.95240232 |
2 | MP0005360_urolithiasis | 3.19234577 |
3 | MP0001835_abnormal_antigen_presentation | 2.89541140 |
4 | MP0005671_abnormal_response_to | 2.76135742 |
5 | MP0004185_abnormal_adipocyte_glucose | 2.70431340 |
6 | MP0001986_abnormal_taste_sensitivity | 2.55860360 |
7 | MP0009785_altered_susceptibility_to | 2.54658849 |
8 | MP0003763_abnormal_thymus_physiology | 2.45026422 |
9 | MP0003303_peritoneal_inflammation | 2.43150961 |
10 | MP0000685_abnormal_immune_system | 2.32480269 |
11 | MP0001790_abnormal_immune_system | 2.27805682 |
12 | MP0005387_immune_system_phenotype | 2.27805682 |
13 | MP0006054_spinal_hemorrhage | 2.27779364 |
14 | MP0002148_abnormal_hypersensitivity_rea | 2.22602199 |
15 | MP0003724_increased_susceptibility_to | 2.18113950 |
16 | MP0002837_dystrophic_cardiac_calcinosis | 2.10775884 |
17 | MP0005000_abnormal_immune_tolerance | 2.10203708 |
18 | MP0005670_abnormal_white_adipose | 2.00892643 |
19 | MP0002723_abnormal_immune_serum | 1.99277042 |
20 | MP0002420_abnormal_adaptive_immunity | 1.94698774 |
21 | MP0001819_abnormal_immune_cell | 1.92697304 |
22 | MP0005025_abnormal_response_to | 1.91765261 |
23 | MP0001800_abnormal_humoral_immune | 1.90182975 |
24 | MP0002452_abnormal_antigen_presenting | 1.89286778 |
25 | MP0005451_abnormal_body_composition | 1.87037849 |
26 | MP0001661_extended_life_span | 1.86917023 |
27 | MP0009333_abnormal_splenocyte_physiolog | 1.86868862 |
28 | MP0002419_abnormal_innate_immunity | 1.84291038 |
29 | MP0000013_abnormal_adipose_tissue | 1.78321156 |
30 | MP0008995_early_reproductive_senescence | 1.76948590 |
31 | MP0002877_abnormal_melanocyte_morpholog | 1.74910665 |
32 | MP0000003_abnormal_adipose_tissue | 1.74885026 |
33 | MP0004130_abnormal_muscle_cell | 1.74720607 |
34 | MP0003436_decreased_susceptibility_to | 1.73098706 |
35 | MP0002405_respiratory_system_inflammati | 1.72850049 |
36 | MP0004510_myositis | 1.69257826 |
37 | MP0002398_abnormal_bone_marrow | 1.67881635 |
38 | MP0002396_abnormal_hematopoietic_system | 1.67545614 |
39 | MP0003646_muscle_fatigue | 1.66962317 |
40 | MP0004947_skin_inflammation | 1.65710839 |
41 | MP0003183_abnormal_peptide_metabolism | 1.57689815 |
42 | MP0000716_abnormal_immune_system | 1.55259746 |
43 | MP0003186_abnormal_redox_activity | 1.50270851 |
44 | MP0006082_CNS_inflammation | 1.50127806 |
45 | MP0006036_abnormal_mitochondrial_physio | 1.49019371 |
46 | MP0002638_abnormal_pupillary_reflex | 1.48897468 |
47 | MP0003172_abnormal_lysosome_physiology | 1.48736201 |
48 | MP0000749_muscle_degeneration | 1.47950290 |
49 | MP0001542_abnormal_bone_strength | 1.46363126 |
50 | MP0002138_abnormal_hepatobiliary_system | 1.46089022 |
51 | MP0000681_abnormal_thyroid_gland | 1.43260390 |
52 | MP0001851_eye_inflammation | 1.41870045 |
53 | MP0000689_abnormal_spleen_morphology | 1.37008288 |
54 | MP0005666_abnormal_adipose_tissue | 1.36303280 |
55 | MP0002909_abnormal_adrenal_gland | 1.35963152 |
56 | MP0003806_abnormal_nucleotide_metabolis | 1.35770349 |
57 | MP0002429_abnormal_blood_cell | 1.34376166 |
58 | MP0000747_muscle_weakness | 1.32895211 |
59 | MP0001845_abnormal_inflammatory_respons | 1.31598199 |
60 | MP0005379_endocrine/exocrine_gland_phen | 1.30370849 |
61 | MP0005464_abnormal_platelet_physiology | 1.29784953 |
62 | MP0009278_abnormal_bone_marrow | 1.29324899 |
63 | MP0002722_abnormal_immune_system | 1.28741749 |
64 | MP0004084_abnormal_cardiac_muscle | 1.27411826 |
65 | MP0004147_increased_porphyrin_level | 1.26626999 |
66 | MP0005076_abnormal_cell_differentiation | 1.26477556 |
67 | MP0003191_abnormal_cellular_cholesterol | 1.26441858 |
68 | MP0000343_altered_response_to | 1.24292108 |
69 | MP0010155_abnormal_intestine_physiology | 1.23324855 |
70 | MP0005058_abnormal_lysosome_morphology | 1.23203689 |
71 | MP0000858_altered_metastatic_potential | 1.23148263 |
72 | MP0002139_abnormal_hepatobiliary_system | 1.23054814 |
73 | MP0000371_diluted_coat_color | 1.21400560 |
74 | MP0003828_pulmonary_edema | 1.19603762 |
75 | MP0001533_abnormal_skeleton_physiology | 1.18990110 |
76 | MP0005397_hematopoietic_system_phenotyp | 1.18740061 |
77 | MP0001545_abnormal_hematopoietic_system | 1.18740061 |
78 | MP0000750_abnormal_muscle_regeneration | 1.18391139 |
79 | MP0002693_abnormal_pancreas_physiology | 1.17862085 |
80 | MP0003279_aneurysm | 1.17379772 |
81 | MP0005645_abnormal_hypothalamus_physiol | 1.16888730 |
82 | MP0004036_abnormal_muscle_relaxation | 1.16275708 |
83 | MP0005375_adipose_tissue_phenotype | 1.14868180 |
84 | MP0009840_abnormal_foam_cell | 1.13529790 |
85 | MP0000678_abnormal_parathyroid_gland | 1.12867963 |
86 | MP0005646_abnormal_pituitary_gland | 1.09330399 |
87 | MP0002132_abnormal_respiratory_system | 1.09172665 |
88 | MP0004233_abnormal_muscle_weight | 1.07223037 |
89 | MP0000703_abnormal_thymus_morphology | 1.06908909 |
90 | MP0008469_abnormal_protein_level | 1.06432951 |
91 | MP0002933_joint_inflammation | 1.05512917 |
92 | MP0005330_cardiomyopathy | 1.04765221 |
93 | MP0003866_abnormal_defecation | 1.02892072 |
94 | MP0005164_abnormal_response_to | 1.01929297 |
95 | MP0003300_gastrointestinal_ulcer | 0.99192178 |
96 | MP0002163_abnormal_gland_morphology | 0.97503518 |
97 | MP0002653_abnormal_ependyma_morphology | 0.94500462 |
98 | MP0001958_emphysema | 0.92697156 |
99 | MP0005310_abnormal_salivary_gland | 0.92398310 |
100 | MP0005075_abnormal_melanosome_morpholog | 0.91255288 |
101 | MP0000230_abnormal_systemic_arterial | 0.90924536 |
102 | MP0001873_stomach_inflammation | 0.90531293 |
103 | MP0003221_abnormal_cardiomyocyte_apopto | 0.88847548 |
104 | MP0001984_abnormal_olfaction | 0.88844019 |
105 | MP0003656_abnormal_erythrocyte_physiolo | 0.87263818 |
106 | MP0008874_decreased_physiological_sensi | 0.86050313 |
107 | MP0001853_heart_inflammation | 0.85619709 |
108 | MP0005165_increased_susceptibility_to | 0.85579736 |
109 | MP0005332_abnormal_amino_acid | 0.84784924 |
110 | MP0005167_abnormal_blood-brain_barrier | 0.84734314 |
111 | MP0001502_abnormal_circadian_rhythm | 0.84624298 |
112 | MP0008007_abnormal_cellular_replicative | 0.84469379 |
113 | MP0005390_skeleton_phenotype | 0.84319455 |
114 | MP0010368_abnormal_lymphatic_system | 0.84120844 |
115 | MP0004808_abnormal_hematopoietic_stem | 0.83554585 |
116 | MP0001764_abnormal_homeostasis | 0.83178562 |
117 | MP0005319_abnormal_enzyme/_coenzyme | 0.82621276 |
118 | MP0009115_abnormal_fat_cell | 0.82361026 |
119 | MP0002332_abnormal_exercise_endurance | 0.81880979 |
120 | MP0009643_abnormal_urine_homeostasis | 0.81745252 |
121 | MP0004782_abnormal_surfactant_physiolog | 0.81038425 |
122 | MP0003075_altered_response_to | 0.81035371 |
123 | MP0005334_abnormal_fat_pad | 0.80963881 |
124 | MP0003453_abnormal_keratinocyte_physiol | 0.80445254 |
125 | MP0001944_abnormal_pancreas_morphology | 0.79529187 |
126 | MP0004215_abnormal_myocardial_fiber | 0.79427779 |
127 | MP0003943_abnormal_hepatobiliary_system | 0.79277042 |
128 | MP0008260_abnormal_autophagy | 0.79122182 |
129 | MP0009764_decreased_sensitivity_to | 0.79121938 |
130 | MP0003045_fibrosis | 0.78474067 |
131 | MP0002095_abnormal_skin_pigmentation | 0.77755319 |
132 | MP0000759_abnormal_skeletal_muscle | 0.77726962 |
133 | MP0002971_abnormal_brown_adipose | 0.77277281 |
134 | MP0009763_increased_sensitivity_to | 0.77237666 |
135 | MP0000249_abnormal_blood_vessel | 0.76984611 |
136 | MP0005166_decreased_susceptibility_to | 0.76457200 |
137 | MP0002998_abnormal_bone_remodeling | 0.76254107 |
138 | MP0004484_altered_response_of | 0.76112419 |
139 | MP0005385_cardiovascular_system_phenoty | 0.75293738 |
140 | MP0001544_abnormal_cardiovascular_syste | 0.75293738 |
141 | MP0010386_abnormal_urinary_bladder | 0.74111218 |
142 | MP0000490_abnormal_crypts_of | 0.73991671 |
143 | MP0001849_ear_inflammation | 0.73360711 |
144 | MP0004043_abnormal_pH_regulation | 0.72802055 |
145 | MP0003137_abnormal_impulse_conducting | 0.72120255 |
146 | MP0006292_abnormal_olfactory_placode | 0.68415479 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of alanine metabolism (HP:0010916) | 6.27460974 |
2 | Hyperalaninemia (HP:0003348) | 6.27460974 |
3 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 6.27460974 |
4 | Spontaneous hematomas (HP:0007420) | 5.27855305 |
5 | Esophageal varix (HP:0002040) | 4.33834681 |
6 | Constricted visual fields (HP:0001133) | 4.19502048 |
7 | Myocardial infarction (HP:0001658) | 3.84819910 |
8 | Congenital sensorineural hearing impairment (HP:0008527) | 3.68772136 |
9 | Abnormal umbilical cord blood vessels (HP:0011403) | 3.65729625 |
10 | Single umbilical artery (HP:0001195) | 3.65729625 |
11 | Abnormality of the fetal cardiovascular system (HP:0010948) | 3.65729625 |
12 | Myopathic facies (HP:0002058) | 3.65534884 |
13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.59696275 |
14 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.59696275 |
15 | Type I transferrin isoform profile (HP:0003642) | 3.45213126 |
16 | Anorexia (HP:0002039) | 3.26177323 |
17 | Vacuolated lymphocytes (HP:0001922) | 3.21121600 |
18 | White forelock (HP:0002211) | 3.19990064 |
19 | Recurrent abscess formation (HP:0002722) | 3.08273969 |
20 | Redundant skin (HP:0001582) | 3.08061675 |
21 | Conjunctival telangiectasia (HP:0000524) | 3.03945222 |
22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.96986319 |
23 | Chronic otitis media (HP:0000389) | 2.91234735 |
24 | Abnormal protein glycosylation (HP:0012346) | 2.90569090 |
25 | Abnormal glycosylation (HP:0012345) | 2.90569090 |
26 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.90569090 |
27 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.90569090 |
28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.88286338 |
29 | Recurrent bronchitis (HP:0002837) | 2.88058761 |
30 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.87927091 |
31 | Hepatocellular necrosis (HP:0001404) | 2.87407469 |
32 | Type 2 muscle fiber atrophy (HP:0003554) | 2.83238174 |
33 | Hepatic necrosis (HP:0002605) | 2.81979702 |
34 | Muscle fiber atrophy (HP:0100295) | 2.79247936 |
35 | Hypothermia (HP:0002045) | 2.77486085 |
36 | Pulmonary embolism (HP:0002204) | 2.77214356 |
37 | Acute necrotizing encephalopathy (HP:0006965) | 2.73659030 |
38 | Abnormality of the umbilical cord (HP:0010881) | 2.71291005 |
39 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.71147674 |
40 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.68715473 |
41 | Abnormality of the nasal mucosa (HP:0000433) | 2.67944530 |
42 | Loss of speech (HP:0002371) | 2.64876877 |
43 | Patchy hypopigmentation of hair (HP:0011365) | 2.64510933 |
44 | Myositis (HP:0100614) | 2.63929531 |
45 | Oligomenorrhea (HP:0000876) | 2.62858251 |
46 | Neuroendocrine neoplasm (HP:0100634) | 2.57703174 |
47 | Mitochondrial inheritance (HP:0001427) | 2.57422639 |
48 | Polygenic inheritance (HP:0010982) | 2.55444233 |
49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.54814999 |
50 | Progressive neurologic deterioration (HP:0002344) | 2.50452235 |
51 | Hypertensive crisis (HP:0100735) | 2.50059528 |
52 | Easy fatigability (HP:0003388) | 2.48737550 |
53 | Hypergammaglobulinemia (HP:0010702) | 2.48545478 |
54 | Nasal polyposis (HP:0100582) | 2.44408445 |
55 | Aortic valve stenosis (HP:0001650) | 2.44010018 |
56 | Homocystinuria (HP:0002156) | 2.41566997 |
57 | Abnormality of homocysteine metabolism (HP:0010919) | 2.41566997 |
58 | Increased IgM level (HP:0003496) | 2.41086416 |
59 | Pheochromocytoma (HP:0002666) | 2.40366876 |
60 | Pustule (HP:0200039) | 2.39893553 |
61 | Hypoalphalipoproteinemia (HP:0003233) | 2.36597268 |
62 | Petechiae (HP:0000967) | 2.36190387 |
63 | IgM deficiency (HP:0002850) | 2.35505655 |
64 | Growth hormone excess (HP:0000845) | 2.35260548 |
65 | Dysostosis multiplex (HP:0000943) | 2.33730929 |
66 | Increased cerebral lipofuscin (HP:0011813) | 2.33363485 |
67 | Panhypogammaglobulinemia (HP:0003139) | 2.33178696 |
68 | Abnormality of macrophages (HP:0004311) | 2.32221195 |
69 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.30753195 |
70 | Ileus (HP:0002595) | 2.30309111 |
71 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.28825109 |
72 | Action tremor (HP:0002345) | 2.26554720 |
73 | Biconcave vertebral bodies (HP:0004586) | 2.26144933 |
74 | Increased muscle lipid content (HP:0009058) | 2.25977726 |
75 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.24700668 |
76 | Poor speech (HP:0002465) | 2.24039095 |
77 | Increased CSF lactate (HP:0002490) | 2.22770279 |
78 | Visceral angiomatosis (HP:0100761) | 2.22707422 |
79 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.21087305 |
80 | Heterochromia iridis (HP:0001100) | 2.20820323 |
81 | Granulocytopenia (HP:0001913) | 2.20277786 |
82 | Abnormality of glycolipid metabolism (HP:0010969) | 2.19985412 |
83 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.19985412 |
84 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.19985412 |
85 | Mediastinal lymphadenopathy (HP:0100721) | 2.19932842 |
86 | Decreased subcutaneous fat (HP:0001002) | 2.18578373 |
87 | Bronchitis (HP:0012387) | 2.18435482 |
88 | Aplastic anemia (HP:0001915) | 2.18309236 |
89 | Exercise intolerance (HP:0003546) | 2.17863025 |
90 | Recurrent bacterial skin infections (HP:0005406) | 2.17452630 |
91 | Mucopolysacchariduria (HP:0008155) | 2.17158313 |
92 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.17158313 |
93 | Elevated alkaline phosphatase (HP:0003155) | 2.15277015 |
94 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.15023879 |
95 | IgG deficiency (HP:0004315) | 2.10672592 |
96 | Joint stiffness (HP:0001387) | 2.10648486 |
97 | Abnormality of T cell physiology (HP:0011840) | 2.09991693 |
98 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.09784644 |
99 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.09784644 |
100 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.09784644 |
101 | Conjugated hyperbilirubinemia (HP:0002908) | 2.08846103 |
102 | Increased intramyocellular lipid droplets (HP:0012240) | 2.08761223 |
103 | Chronic sinusitis (HP:0011109) | 2.08608869 |
104 | Gastrointestinal stroma tumor (HP:0100723) | 2.07977468 |
105 | Abnormality of T cells (HP:0002843) | 2.07772088 |
106 | Recurrent fungal infections (HP:0002841) | 2.06675968 |
107 | Cervical subluxation (HP:0003308) | 2.06496087 |
108 | Esophageal neoplasm (HP:0100751) | 2.06040592 |
109 | Neoplasm of head and neck (HP:0012288) | 2.06040592 |
110 | Systemic lupus erythematosus (HP:0002725) | 2.05995095 |
111 | Gingival bleeding (HP:0000225) | 2.05772483 |
112 | Diaphragmatic weakness (HP:0009113) | 2.04932195 |
113 | Basal ganglia calcification (HP:0002135) | 2.04499192 |
114 | Increased serum lactate (HP:0002151) | 2.03505722 |
115 | Back pain (HP:0003418) | 2.03420592 |
116 | Arterial thrombosis (HP:0004420) | 2.03215250 |
117 | Agammaglobulinemia (HP:0004432) | 2.02563087 |
118 | 3-Methylglutaconic aciduria (HP:0003535) | 2.01725858 |
119 | Eczematoid dermatitis (HP:0000976) | 2.00905635 |
120 | Generalized aminoaciduria (HP:0002909) | 2.00712395 |
121 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.00314915 |
122 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99238900 |
123 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99238900 |
124 | Nausea (HP:0002018) | 1.99216859 |
125 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.99102534 |
126 | Hypoplastic left heart (HP:0004383) | 1.98614002 |
127 | Vertebral compression fractures (HP:0002953) | 1.98083686 |
128 | Recurrent viral infections (HP:0004429) | 1.97916238 |
129 | Cortical visual impairment (HP:0100704) | 1.97108381 |
130 | Lactic acidosis (HP:0003128) | 1.97087833 |
131 | Toxemia of pregnancy (HP:0100603) | 1.95429397 |
132 | Purpura (HP:0000979) | 1.95057658 |
133 | Axonal loss (HP:0003447) | 1.94904731 |
134 | Reduced antithrombin III activity (HP:0001976) | 1.94561545 |
135 | Cavernous hemangioma (HP:0001048) | 1.94269760 |
136 | Emphysema (HP:0002097) | 1.93981895 |
137 | Stomatitis (HP:0010280) | 1.93971793 |
138 | Nonprogressive disorder (HP:0003680) | 1.93364417 |
139 | Ragged-red muscle fibers (HP:0003200) | 1.93354975 |
140 | Palpitations (HP:0001962) | 1.92995491 |
141 | Acute encephalopathy (HP:0006846) | 1.92521247 |
142 | Hypertriglyceridemia (HP:0002155) | 1.92170094 |
143 | Progressive muscle weakness (HP:0003323) | 1.92077665 |
144 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.91273569 |
145 | Patent foramen ovale (HP:0001655) | 1.90252102 |
146 | Distal lower limb amyotrophy (HP:0008944) | 1.89877760 |
147 | Urticaria (HP:0001025) | 1.89738683 |
148 | Bulbar palsy (HP:0001283) | 1.89695416 |
149 | Papilledema (HP:0001085) | 1.89266921 |
150 | Fatigue (HP:0012378) | 1.89098459 |
151 | Thrombophlebitis (HP:0004418) | 1.88892259 |
152 | Progressive macrocephaly (HP:0004481) | 1.88805969 |
153 | Abnormality of dental color (HP:0011073) | 1.87947435 |
154 | Hemangiomatosis (HP:0007461) | 1.87295641 |
155 | Large for gestational age (HP:0001520) | 1.86891497 |
156 | Beaking of vertebral bodies (HP:0004568) | 1.86624042 |
157 | Epistaxis (HP:0000421) | 1.86147477 |
158 | Abnormality of T cell number (HP:0011839) | 1.84527118 |
159 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.84272179 |
160 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.84218105 |
161 | Retinal dysplasia (HP:0007973) | 1.82541794 |
162 | Thin bony cortex (HP:0002753) | 1.82132803 |
163 | Distal lower limb muscle weakness (HP:0009053) | 1.80577150 |
164 | Abnormality of the peritoneum (HP:0002585) | 1.80353445 |
165 | Microcytic anemia (HP:0001935) | 1.80258747 |
166 | Spinal canal stenosis (HP:0003416) | 1.78689064 |
167 | Dilated cardiomyopathy (HP:0001644) | 1.77842412 |
168 | Hemoptysis (HP:0002105) | 1.77397924 |
169 | Gastrointestinal dysmotility (HP:0002579) | 1.76892686 |
170 | Degeneration of anterior horn cells (HP:0002398) | 1.76886285 |
171 | Abnormality of the anterior horn cell (HP:0006802) | 1.76886285 |
172 | T lymphocytopenia (HP:0005403) | 1.75929248 |
173 | B lymphocytopenia (HP:0010976) | 1.75759491 |
174 | Abnormality of B cell number (HP:0010975) | 1.75759491 |
175 | Severe combined immunodeficiency (HP:0004430) | 1.75646230 |
176 | Birth length less than 3rd percentile (HP:0003561) | 1.75479135 |
177 | Restrictive lung disease (HP:0002091) | 1.73018240 |
178 | Difficulty climbing stairs (HP:0003551) | 1.71960251 |
179 | Increased serum ferritin (HP:0003281) | 1.67248060 |
180 | Insomnia (HP:0100785) | 1.66828499 |
181 | Increased IgE level (HP:0003212) | 1.65581110 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP2K3 | 5.11938372 |
2 | TRIB3 | 2.91106952 |
3 | MAP4K1 | 2.91021384 |
4 | NME2 | 2.80350636 |
5 | TBK1 | 2.70719648 |
6 | PIM2 | 2.69155489 |
7 | IRAK3 | 2.41780843 |
8 | IRAK4 | 2.32602095 |
9 | CAMKK2 | 2.30620727 |
10 | TXK | 2.30448670 |
11 | KIT | 2.26794707 |
12 | SIK3 | 2.25357541 |
13 | MAPK15 | 2.21885021 |
14 | TAOK2 | 2.08356497 |
15 | ARAF | 2.06844336 |
16 | ACVR1B | 2.04351449 |
17 | MAP3K14 | 2.02440325 |
18 | FLT3 | 1.97831127 |
19 | TEC | 1.96127967 |
20 | ZAP70 | 1.93334797 |
21 | PINK1 | 1.92227810 |
22 | MAP3K12 | 1.91541326 |
23 | CDK9 | 1.90990701 |
24 | CCNB1 | 1.88302219 |
25 | KDR | 1.85379075 |
26 | TGFBR2 | 1.83887799 |
27 | SIK1 | 1.80714264 |
28 | BCKDK | 1.79194278 |
29 | MYLK | 1.76625992 |
30 | ERN1 | 1.73278914 |
31 | FGR | 1.72933295 |
32 | IKBKE | 1.65583007 |
33 | RPS6KB2 | 1.65563767 |
34 | STK16 | 1.65271130 |
35 | JAK3 | 1.63218924 |
36 | MAP3K13 | 1.60787307 |
37 | SMG1 | 1.56774072 |
38 | BTK | 1.54418005 |
39 | IKBKB | 1.35459237 |
40 | TIE1 | 1.31383053 |
41 | MAP3K11 | 1.29973744 |
42 | PRKD3 | 1.29331606 |
43 | TAOK1 | 1.26698706 |
44 | NLK | 1.26045494 |
45 | EIF2AK1 | 1.24014468 |
46 | EPHA3 | 1.23346621 |
47 | TESK2 | 1.21794412 |
48 | TTN | 1.14355056 |
49 | SYK | 1.13626755 |
50 | TYK2 | 1.12383385 |
51 | CDK8 | 1.07964797 |
52 | MOS | 1.07675098 |
53 | NME1 | 1.07543275 |
54 | ITK | 1.04794831 |
55 | HIPK2 | 1.04389868 |
56 | BMPR2 | 1.01211639 |
57 | MAPK11 | 0.95118815 |
58 | TNK2 | 0.93111707 |
59 | EPHB2 | 0.92325214 |
60 | MUSK | 0.91917430 |
61 | BRSK2 | 0.91690839 |
62 | MATK | 0.90843478 |
63 | PAK4 | 0.90056943 |
64 | GRK6 | 0.83986066 |
65 | PASK | 0.83259620 |
66 | PTK6 | 0.82887762 |
67 | MAP2K1 | 0.82663165 |
68 | INSRR | 0.82210196 |
69 | SGK494 | 0.81592023 |
70 | SGK223 | 0.81592023 |
71 | PRKCI | 0.81166718 |
72 | IRAK1 | 0.80262095 |
73 | GRK7 | 0.80024348 |
74 | ICK | 0.78709420 |
75 | MAPKAPK3 | 0.77239593 |
76 | SGK3 | 0.76788433 |
77 | TESK1 | 0.75960446 |
78 | MAP2K7 | 0.75118952 |
79 | RPS6KA6 | 0.74448364 |
80 | NEK9 | 0.73674134 |
81 | PRKCH | 0.72247085 |
82 | CSF1R | 0.69854827 |
83 | NTRK2 | 0.69312256 |
84 | EPHA2 | 0.68846893 |
85 | LMTK2 | 0.68536649 |
86 | KSR2 | 0.68258713 |
87 | PRKG2 | 0.67231527 |
88 | TNIK | 0.66936421 |
89 | PRKD2 | 0.65911651 |
90 | MAP2K2 | 0.65563793 |
91 | DAPK1 | 0.65552775 |
92 | RPS6KA4 | 0.63770929 |
93 | RPS6KL1 | 0.62995472 |
94 | RPS6KC1 | 0.62995472 |
95 | CAMKK1 | 0.62145543 |
96 | LCK | 0.61825053 |
97 | MARK3 | 0.61642558 |
98 | TSSK6 | 0.61631518 |
99 | MAPK12 | 0.61438049 |
100 | LYN | 0.61223107 |
101 | VRK1 | 0.60572969 |
102 | SGK2 | 0.59545601 |
103 | MAP3K3 | 0.59351706 |
104 | TYRO3 | 0.58753941 |
105 | MAP3K6 | 0.58741855 |
106 | MAP3K9 | 0.58675907 |
107 | PIK3CG | 0.57971184 |
108 | PKN2 | 0.57137899 |
109 | CDK19 | 0.56583730 |
110 | DAPK3 | 0.56554005 |
111 | PDK2 | 0.55930927 |
112 | MTOR | 0.55817187 |
113 | RIPK4 | 0.55627985 |
114 | CAMK1 | 0.55452959 |
115 | WNK3 | 0.55045209 |
116 | SIK2 | 0.54194965 |
117 | LRRK2 | 0.54121717 |
118 | RIPK1 | 0.53691400 |
119 | IRAK2 | 0.53414897 |
120 | PDPK1 | 0.52972168 |
121 | MAP3K1 | 0.52916092 |
122 | PRKCD | 0.52636311 |
123 | PIM1 | 0.52348714 |
124 | DAPK2 | 0.51901167 |
125 | BRAF | 0.51752503 |
126 | ABL2 | 0.51080049 |
127 | RAF1 | 0.49730915 |
128 | FES | 0.49487633 |
129 | STK24 | 0.49050757 |
130 | MAPK7 | 0.46089263 |
131 | PRPF4B | 0.46016946 |
132 | TAOK3 | 0.45488015 |
133 | JAK2 | 0.45375158 |
134 | CAMK2G | 0.45271185 |
135 | ADRBK2 | 0.45099840 |
136 | ADRBK1 | 0.43904626 |
137 | BRSK1 | 0.43795300 |
138 | JAK1 | 0.43035841 |
139 | TGFBR1 | 0.42905545 |
140 | MAPKAPK2 | 0.42536556 |
141 | VRK2 | 0.41170916 |
142 | PHKG1 | 0.40639550 |
143 | PHKG2 | 0.40639550 |
144 | LIMK1 | 0.40363436 |
145 | RPS6KA2 | 0.39917232 |
146 | CSK | 0.38576326 |
147 | ZAK | 0.37526622 |
148 | BLK | 0.37482021 |
149 | RPS6KA1 | 0.36621417 |
150 | STK10 | 0.35596203 |
151 | MARK2 | 0.35356968 |
152 | MAP3K8 | 0.35079741 |
153 | BRD4 | 0.34943308 |
154 | CHUK | 0.34726759 |
155 | CDK4 | 0.34429212 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sulfur relay system_Homo sapiens_hsa04122 | 3.35412866 |
2 | Protein export_Homo sapiens_hsa03060 | 2.95875783 |
3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.73798519 |
4 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.64416910 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.62910481 |
6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.58825817 |
7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.41017283 |
8 | Proteasome_Homo sapiens_hsa03050 | 2.39983713 |
9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.39381938 |
10 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.32640782 |
11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.28924443 |
12 | DNA replication_Homo sapiens_hsa03030 | 2.26918204 |
13 | RNA polymerase_Homo sapiens_hsa03020 | 2.12149415 |
14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.04340225 |
15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.97935093 |
16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.77126870 |
17 | Lysosome_Homo sapiens_hsa04142 | 1.72645937 |
18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.70877232 |
19 | Base excision repair_Homo sapiens_hsa03410 | 1.66049421 |
20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.64330284 |
21 | Prion diseases_Homo sapiens_hsa05020 | 1.61563764 |
22 | Legionellosis_Homo sapiens_hsa05134 | 1.56245042 |
23 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.52559168 |
24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.50039613 |
25 | Ribosome_Homo sapiens_hsa03010 | 1.48509772 |
26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.48102116 |
27 | Mismatch repair_Homo sapiens_hsa03430 | 1.47660668 |
28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.47048618 |
29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.45708945 |
30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38787800 |
31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.31339280 |
32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.30480678 |
33 | Purine metabolism_Homo sapiens_hsa00230 | 1.30192657 |
34 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.29434431 |
35 | Measles_Homo sapiens_hsa05162 | 1.26928040 |
36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.25661131 |
37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24157135 |
38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.21372084 |
39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.20173528 |
40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.17322327 |
41 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.17021874 |
42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.16252435 |
43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15902466 |
44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14960742 |
45 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.11455566 |
46 | Bladder cancer_Homo sapiens_hsa05219 | 1.09444150 |
47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.09253431 |
48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08818391 |
49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08069301 |
50 | Leishmaniasis_Homo sapiens_hsa05140 | 1.05394813 |
51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05361022 |
52 | Morphine addiction_Homo sapiens_hsa05032 | 1.04004228 |
53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03244057 |
54 | Galactose metabolism_Homo sapiens_hsa00052 | 1.02856904 |
55 | Allograft rejection_Homo sapiens_hsa05330 | 1.02586934 |
56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00668517 |
57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.99969206 |
58 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.97703961 |
59 | Olfactory transduction_Homo sapiens_hsa04740 | 0.97331862 |
60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96193689 |
61 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.94442383 |
62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94382210 |
63 | Insulin secretion_Homo sapiens_hsa04911 | 0.94185830 |
64 | Homologous recombination_Homo sapiens_hsa03440 | 0.92983851 |
65 | Shigellosis_Homo sapiens_hsa05131 | 0.92324521 |
66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.91979900 |
67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91162855 |
68 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.90107348 |
69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.89487271 |
70 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.85597857 |
71 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.85593725 |
72 | GABAergic synapse_Homo sapiens_hsa04727 | 0.83899172 |
73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81687766 |
74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79610814 |
75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79574881 |
76 | Pertussis_Homo sapiens_hsa05133 | 0.78994130 |
77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.78792305 |
78 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78783162 |
79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78664763 |
80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.77614511 |
81 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.77472905 |
82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.77056169 |
83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76101208 |
84 | Apoptosis_Homo sapiens_hsa04210 | 0.74932820 |
85 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74834146 |
86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73838805 |
87 | Tuberculosis_Homo sapiens_hsa05152 | 0.72197129 |
88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72084787 |
89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70704604 |
90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69347647 |
91 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69152831 |
92 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68805393 |
93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67349279 |
94 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65980925 |
95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65668155 |
96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65136209 |
97 | Hepatitis C_Homo sapiens_hsa05160 | 0.64616766 |
98 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64518069 |
99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62464644 |
100 | Malaria_Homo sapiens_hsa05144 | 0.61745633 |
101 | Phagosome_Homo sapiens_hsa04145 | 0.60766959 |
102 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60315280 |
103 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.58152647 |
104 | Influenza A_Homo sapiens_hsa05164 | 0.57446589 |
105 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57280140 |
106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.57058182 |
107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56453353 |
108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56427076 |
109 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.56184366 |
110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54369748 |
111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51909734 |
112 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.51840432 |
113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51787334 |
114 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50151573 |
115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49958573 |
116 | Hepatitis B_Homo sapiens_hsa05161 | 0.49469744 |
117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49129824 |
118 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48897241 |
119 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47892797 |
120 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.45955680 |
121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45708300 |
122 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45192102 |
123 | Endocytosis_Homo sapiens_hsa04144 | 0.44688667 |
124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44645599 |
125 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44610137 |
126 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.43844593 |
127 | Salmonella infection_Homo sapiens_hsa05132 | 0.43029700 |
128 | RNA degradation_Homo sapiens_hsa03018 | 0.42821376 |
129 | Spliceosome_Homo sapiens_hsa03040 | 0.42412309 |
130 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41503523 |
131 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41342909 |
132 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40326102 |
133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40121429 |
134 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39994869 |
135 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.35907549 |
136 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35268372 |
137 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35014677 |
138 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.33588030 |
139 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33532299 |
140 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33409826 |
141 | Viral myocarditis_Homo sapiens_hsa05416 | 0.31996518 |